UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in paediatric functional constipation diagnosis and treatment and how to avoid them

Marc Benninga, Ilan Koppen, fleur de lorijn, Max Nieuwdorp

Summary

AI Generated

Functional constipation, defined as constipation without an organic cause, affects approximately 9.5% of children and adolescents worldwide and accounts for about 95% of paediatric constipation cases.

  • Approximately 95% of children with constipation have no identifiable organic cause and are classified as having functional constipation.
  • The worldwide prevalence of functional constipation in children and adolescents is 9.5%.
  • Constipation in children may present with infrequent bowel movements, faecal incontinence, hard or large stools, painful defaecation, or abdominal pain.
  • This material is most relevant to paediatricians and gastroenterologists managing constipation in children.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10
1.
Koppen IJN, Vriesman MH, Saps M, et al. Prevalence of functional defecation disorders in children: A systematic review and meta-analysis. The Journal of Pediatrics 2018; 198: 121-30.e6 [Link]
2.
Choung RS, Shah ND, Chitkara D, et al. Direct medical costs of constipation from childhood to early adulthood: A population-based birth cohort study. J Pediatr Gastroenterol Nutr 2011; 52: 47-54 [Link]
3.
Liem O, Harman J, Benninga M, et al. Health utilization and cost impact of childhood constipation in the united states. J Pediatr 2009; 154: 258-262 [Link]
4.
Park R, Mikami S, LeClair J, et al. Inpatient burden of childhood functional gi disorders in the USA: An analysis of national trends in the USA from 1997 to 2009. Neurogastroenterol Motil 2015; 27: 684-692 [Link]
5.
Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: Evidence-based recommendations from espghan and naspghan. J Pediatr Gastroenterol Nutr 2014; 58: 258-74 [Link]
6.
Koppen IJ, Nurko S, Saps M, et al. The pediatric rome iv criteria: What's new? Expert Rev Gastroenterol Hepatol 2017; 11: 193-201 [Link]
7.
Tabbers MM, Di Lorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: Evidence-based recommendations from espghan and naspghan. Journal of pediatric gastroenterology and nutrition 2014; 58: 258-74 [Link]
8.
Rajindrajith S, Devanarayana NM, Thapar N, et al. Myths and misconceptions about childhood constipation. Eur J Pediatr 2023; 182: 1447-58 [Link]
9.
Bouzios I, Chouliaras G, Chrousos GP, et al. Functional gastrointestinal disorders in greek children based on rome iii criteria: Identifying the child at risk. Neurogastroenterol Motil 2017; 29: e12951 [Link]
10.
Lewis ML, Palsson OS, Whitehead WE, et al. Prevalence of functional gastrointestinal disorders in children and adolescents. J Pediatr 2016; 177: 39-43.e3 [Link]
11.
Hasosah M, Alsahafi F, Alghiribi A, et al. Prevalence, characterization and risk factors of chronic constipation among saudi children: A cross-sectional study International Journal of Advanced Research 2018; 6: 1319-1324 [Link]
12.
Ip KS, Lee WT, Chan JS, et al. A community-based study of the prevalence of constipation in young children and the role of dietary fibre. Hong Kong Med J 2005; 11: 431-436 [Link]
13.
Wu TC, Chen LK, Pan WH, et al. Constipation in taiwan elementary school students: A nationwide survey. J Chin Med Assoc 2011; 74: 57-61 [Link]
14.
Udoh EE, Rajindrajith S, Devanarayana NM, et al. Prevalence and risk factors for functional constipation in adolescent nigerians. Arch Dis Child 2017; 102: 841-844 [Link]
15.
Lu PL, Velasco-Benítez CA and Saps M. Sex, age, and prevalence of pediatric irritable bowel syndrome and constipation in colombia: A population-based study. J Pediatr Gastroenterol Nutr 2017; 64: e137-e41 [Link]
16.
Chogle A, Velasco-Benitez CA, Koppen IJ, et al. A population-based study on the epidemiology of functional gastrointestinal disorders in young children. J Pediatr 2016; 179: 139-43.e1 [Link]
17.
Berger MY, Tabbers MM, Kurver MJ, et al. Value of abdominal radiography, colonic transit time, and rectal ultrasound scanning in the diagnosis of idiopathic constipation in children: A systematic review. J Pediatr 2012; 161: 44-50.e1-2 [Link]
18.
Benninga MA, Tabbers MM and van Rijn RR. How to use a plain abdominal radiograph in children with functional defecation disorders. Arch Dis Child Educ Pract Ed 2016; 101: 187-193 [Link]
19.
Yallanki N, Small-Harary L, Morganstern J, et al. Inter and intraobserver variation in interpretation of fecal loading on abdominal radiographs. J Pediatr Gastroenterol Nutr 2023; 76: 295-299 [Link]
20.
Hyams JS, Di Lorenzo C, Saps M, et al. Functional disorders: Children and adolescents. Gastroenterology 2016; 150: 1456-1468 [Link]
21.
Benninga MA, Faure C, Hyman PE, et al. Childhood functional gastrointestinal disorders: Neonate/toddler. Gastroenterology 2016; 150: 1443-1455.e2 [Link]
22.
Pradhan S and Jagadisan B. Yield and examiner dependence of digital rectal examination in detecting impaction in pediatric functional constipation. Journal of Pediatric Gastroenterology and Nutrition 2018; 67: 570-5. [Link]
23.
Orenstein SR and Wald A. Pediatric rectal exam: Why, when, and how. Curr Gastroenterol Rep 2016; 18: 4 [Link]
24.
Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: Evidence-based recommendations from espghan and naspghan. J Pediatr Gastroenterol Nutr 2014; 58: 258-274 [Link]
25.
Bekkali NL, van den Berg MM, Dijkgraaf MG, et al. Rectal fecal impaction treatment in childhood constipation: Enemas versus high doses oral peg. Pediatrics 2009; 124: e1108-1115 [Link]
26.
Morais MB, Vítolo MR, Aguirre AN, et al. Measurement of low dietary fiber intake as a risk factor for chronic constipation in children. J Pediatr Gastroenterol Nutr 1999; 29: 132-135 [Link]
27.
Roma E, Adamidis D, Nikolara R, et al. Diet and chronic constipation in children: The role of fiber. J Pediatr Gastroenterol Nutr 1999; 28: 169-174 [Link]
28.
Lee WT, Ip KS, Chan JS, et al. Increased prevalence of constipation in pre-school children is attributable to under-consumption of plant foods: A community-based study. J Paediatr Child Health 2008; 44: 170-175 [Link]
29.
Korczak R, Kamil A, Fleige L, et al. Dietary fiber and digestive health in children. Nutr Rev 2017; 75: 241-259 [Link]
30.
Salvatore S, Battigaglia MS, Murone E, et al. Dietary fibers in healthy children and in pediatric gastrointestinal disorders: A practical guide. Nutrients 2023; 15: 2208 [Link]
31.
Bardisa-Ezcurra L, Ullman R and Gordon J. Diagnosis and management of idiopathic childhood constipation: Summary of nice guidance. Bmj 2010; 340: c2585 [Link]
32.
Hojsak I, Benninga MA, Hauser B, et al. Benefits of dietary fibre for children in health and disease. Arch Dis Child 2022; 107: 973-979 [Link]
33.
Axelrod CH and Saps M. The role of fiber in the treatment of functional gastrointestinal disorders in children. Nutrients 2018; 10: 1650 [Link]
34.
Piccoli de Mello P, Eifer DA and Daniel de Mello E. Use of fibers in childhood constipation treatment: Systematic review with meta-analysis. J Pediatr (Rio J) 2018; 94: 460-470 [Link]
35.
Wegh CAM, Baaleman DF, Tabbers MM, et al. Nonpharmacologic treatment for children with functional constipation: A systematic review and meta-analysis. J Pediatr 2022; 240: 136-149.e5 [Link]
36.
Wegh CAM, Schoterman MHC, Vaughan EE, et al. The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome. Expert Rev Gastroenterol Hepatol 2017; 11: 1031-1045 [Link]
37.
Todhunter-Brown A, Booth L, Campbell P, et al. Strategies used for childhood chronic functional constipation: The success evidence synthesis. Health Technol Assess 2024; 28: 1-266. [Link]
38.
Fei D, Mengyang H, Yifei D, et al. Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: A systematic review and meta-analysis. BMJ Open 2024; 14: e074557. [Link]
39.
Dimidi E, Christodoulides S, Fragkos KC, et al. The effect of probiotics on functional constipation in adults: A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2014; 100: 1075-84. 20140806. [Link]
40.
Miller LE, Zimmermann AK and Ouwehand AC. Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit. World J Gastroenterol 2016; 22: 5122-31. [Link]
41.
Koppen IJN, De Meij TGJ and Benninga MA. Investigating probiotics in the management of childhood functional constipation: A never-ending story? Indian Pediatr 2023 20230320. [Link]
42.
Kwiatkowska M and Krogulska A. The significance of the gut microbiome in children with functional constipation. Adv Clin Exp Med 2021; 30: 471-80. [Link]
43.
Wallace C, Sinopoulou V, Gordon M, et al. Probiotics for treatment of chronic constipation in children. Cochrane Database Syst Rev 2022; 3: Cd014257. 20220329. [Link]
44.
de Geus A, Koppen IJN, Flint RB, et al. An update of pharmacological management in children with functional constipation. Paediatr Drugs 2023; 25: 343-58. 20230320. [Link]
45.
Felt B, Wise CG, Olson A, et al. Guideline for the management of pediatric idiopathic constipation and soiling. Multidisciplinary team from the university of michigan medical center in ann arbor. Arch Pediatr Adolesc Med 1999; 153: 380-385 [Link]
46.
Bekkali NLH, Hoekman DR, Liem O, et al. Polyethylene glycol 3350 with electrolytes versus polyethylene glycol 4000 for constipation: A randomized, controlled trial. J Pediatr Gastroenterol Nutr 2018; 66: 10-15 [Link]
47.
Rachel H, Griffith AF, Teague WJ, et al. Polyethylene glycol dosing for constipation in children younger than 24 months: A systematic review. J Pediatr Gastroenterol Nutr 2020; 71: 171-175 [Link]
48.
Roy D, Akriche F, Amlani B, et al. Utilisation and safety of polyethylene glycol 3350 with electrolytes in children under 2 years: A retrospective cohort. J Pediatr Gastroenterol Nutr 2021; 72: 683-689 [Link]
49.
Strisciuglio C, Coppola V, Russo M, et al. Promelaxin microenemas are non-inferior to oral polyethylene glycol for the treatment of functional constipation in young children: A randomized clinical trial. Front Pediatr 2021; 9: 753938 [Link]
50.
Bonilla S, Nurko S and Rodriguez L. Long-term use of bisacodyl in pediatric functional constipation refractory to conventional therapy. J Pediatr Gastroenterol Nutr 2020; 71: 288-291 [Link]
51.
Bouchoucha M, Amand C, De Fer BB, et al. A retrospective real-world observational study assessing the evolution of bisacodyl prescriptions in patients with constipation during long-term treatment. Drugs Real World Outcomes 2023; 10: 249-261 [Link]
52.
Noergaard M, Traerup Andersen J, Jimenez-Solem E, et al. Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety? Scand J Gastroenterol 2019; 54: 27-34 [Link]
53.
Santos-Jasso KA, Arredondo-García JL, Maza-Vallejos J, et al. Effectiveness of senna vs polyethylene glycol as laxative therapy in children with constipation related to anorectal malformation. J Pediatr Surg 2017; 52: 84-88 [Link]
54.
Vilanova-Sanchez A, Gasior AC, Toocheck N, et al. Are senna based laxatives safe when used as long term treatment for constipation in children? J Pediatr Surg 2018; 53: 722-727 [Link]
55.
DiMatteo MR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004; 42: 200-209 [Link]
56.
Reeves PT, Jack BO, Rogers PL, et al. The uniformed services constipation action plan: An effective tool for the management of children with functional constipation. J Pediatr 2023; 253: 46-54.e1 [Link]
57.
Koppen IJN, van Wassenaer EA, Barendsen RW, et al. Adherence to polyethylene glycol treatment in children with functional constipation is associated with parental illness perceptions, satisfaction with treatment, and perceived treatment convenience. J Pediatr 2018; 199: 132-139.e1 [Link]
58.
Steiner SA, Torres MR, Penna FJ, et al. Chronic functional constipation in children: Adherence and factors associated with drug treatment. J Pediatr Gastroenterol Nutr 2014; 58: 598-602 [Link]
59.
Krassas G, Cranswick N, Katelaris P, et al. Polyethylene glycols with or without electrolytes for constipation in children: A network meta-analysis. Pediatrics & Therapeutics 2018; 8: 1-10 [Link]
60.
Santucci NR, Rein LE, van Tilburg MA, et al. Self-efficacy in children with functional constipation is associated with treatment success. J Pediatr 2020; 216: 19-24 [Link]
61.
Koppen IJ, Lammers LA, Benninga MA, et al. Management of functional constipation in children: Therapy in practice. Paediatr Drugs 2015; 17: 349-360 [Link]
62.
Mosiello G, Marshall D, Rolle U, et al. Consensus review of best practice of transanal irrigation in children. J Pediatr Gastroenterol Nutr 2017; 64: 343-352 [Link]
63.
Bokova E, Svetanoff WJ, Rosen JM, et al. State of the art bowel management for pediatric colorectal problems: Functional constipation. Children (Basel) 2023; 10: 1078 [Link]
64.
Baaleman DF, Wegh CAM, Hoogveld MTA, Benninga MA, Koppen IJN. Transanal Irrigation in Children: Treatment Success, Quality of Life, Adherence, Patient Experience, and Independence. J Pediatr Gastroenterol Nutr. 2022;75: 166-172 [Link]
65.
Koppen IJ, Kuizenga-Wessel S, Voogt HW, Voskeuil ME, Benninga MA. Transanal Irrigation in the Treatment of Children With Intractable Functional Constipation. J Pediatr Gastroenterol Nutr. 2017; 64: 225-259 [Link]

Abstract

Constipation is a bothersome problem for many children. It may present with any of the following symptoms; infrequent bowel movements, faecal incontinence, hard or large stools, painful defaecation and abdominal pain. No organic cause is found in approximately 95% of children with constipation—these children are considered to suffer from functional constipation. Functional constipation is a common disorder in children and adolescents, with a worldwide prevalence of 9.5%!

Topics

Neurogastroenterology & Motility Paediatrics

Published

2024

More Like This:

Gut brain axis

Gut brain axis

Jutta Keller Jutta Keller

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino, Iago Rodríguez-Lago

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris Peter Katelaris

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol Jolien Schol

Panel discussion: What's new on diverticular disease of the colon

Panel discussion: What's new on diverticular disease of the colon

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Gut brain axis

Jutta Keller 1

Affiliations

1 Israelitic Krankenhaus, Hamburg, Germany

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Neurogastroenterology & Motility

Published

2024

More Like This:

Gut brain axis

Gut brain axis

Jutta Keller Jutta Keller

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino, Iago Rodríguez-Lago

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris Peter Katelaris

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol Jolien Schol

Panel discussion: What's new on diverticular disease of the colon

Panel discussion: What's new on diverticular disease of the colon

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino

UEG Podcast Episode
Journal Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Iago Rodríguez-Lago 1, Edoardo Vincenzo Savarino 2

Affiliations

1 Hospital Universitario de Galdakao, Bilbao, Spain

2 Division of Gastroenterology, University of Padua, Italy

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Neurogastroenterology & Motility

Published

2022

More Like This:

Gut brain axis

Gut brain axis

Jutta Keller Jutta Keller

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino, Iago Rodríguez-Lago

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris Peter Katelaris

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol Jolien Schol

Panel discussion: What's new on diverticular disease of the colon

Panel discussion: What's new on diverticular disease of the colon

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino

UEG Standards and Guidelines
Position Paper
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline

Summary

Helicobacter pylori continues to be a major health problem worldwide, causing considerable morbidity and mortality due to peptic ulcer disease and gastric cancer.

The burden of disease falls disproportionately on less well-resourced populations. As with most infectious diseases, the greatest impact on reducing this burden comes from improvements in socioeconomic status, which interrupt transmission. This has been observed in many regions of the world, but the prevalence of infection remains high in many regions in which improvements in living standards are slow to occur.

Meanwhile, the optimal clinical management and treatment pathways remain unsettled and are evolving with changing antimicrobial resistance patterns. Despite decades of research and clinical practice, major challenges remain. The quest for the most effective, safe, and simple therapy is still a major issue for clinicians. An effective vaccine also still appears to be elusive.

Clinical guidelines not infrequently proffer discordant advice. It is very difficult for guidelines to achieve relevance across a variety of populations with varying spectrums of disease, antimicrobial resistance rates, and vastly different resources. As local factors are central to determining the impact and management strategies for H. pylori infection, it is important for pathways to be based on the best available local knowledge, rather than solely extrapolated from guidelines formulated in other regions, which may be less applicable. To this end, this revision of the WGO H. pylori guideline uses a “cascades” approach that seeks to summarize the principles of management and offer advice for pragmatic, relevant, and achievable diagnostic and treatment pathways based on established key treatment principles and using local knowledge and available resources to guide regional practice.

Keywords: H. pylori, stomach, peptic ulcer, gastric cancer, dyspepsia, antibiotics

Guideline

Position Paper

Topics

Stomach & H. Pylori

Citation

World Gastroenterology Organisation, 2021

Published

2021

More Like This:

Gut brain axis

Gut brain axis

Jutta Keller Jutta Keller

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino, Iago Rodríguez-Lago

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris Peter Katelaris

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol Jolien Schol

Panel discussion: What's new on diverticular disease of the colon

Panel discussion: What's new on diverticular disease of the colon

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino

UEG Standards and Guidelines
Consensus
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline


Abstract

Background

Gastroparesis is a condition characterized by epigastric symptoms and delayed gastric emptying (GE) rate in the absence of any mechanical obstruction. The condition is challenging in clinical practice by the lack of guidance concerning diagnosis and management of gastroparesis.

Methods

A Delphi consensus was undertaken by 40 experts from 19 European countries who conducted a literature summary and voting process on 89 statements. Quality of evidence was evaluated using grading of recommendations assessment, development, and evaluation criteria. Consensus (defined as >=80% agreement) was reached for 25 statements.

Results

The European consensus defined gastroparesis as the presence of symptoms associated with delayed GE in the absence of mechanical obstruction. Nausea and vomiting were identified as cardinal symptoms, with often coexisting postprandial distress syndrome symptoms of dyspepsia. The true epidemiology of gastroparesis is not known in detail, but diabetes, gastric surgery, certain neurological and connective tissue diseases, and the use of certain drugs recognized as risk factors. While the panel agreed that severely impaired gastric motor function is present in these patients, there was no consensus on underlying pathophysiology. The panel agreed that an upper endoscopy and a GE test are required for diagnosis. Only dietary therapy, dopamine-2 antagonists and 5-HT4 receptor agonists were considered appropriate therapies, in addition to nutritional support in case of severe weight loss. No consensus was reached on the use of proton pump inhibitors, other classes of antiemetics or prokinetics, neuromodulators, complimentary, psychological, or more invasive therapies. Finally, there was consensus that gastroparesis adversely impacts on quality of life and healthcare costs and that the long-term prognosis of gastroparesis depends on the cause.

Conclusions and Inferences

A multinational group of European experts summarized the current state of consensus on definition, symptom characteristics, pathophysiology, diagnosis, and management of gastroparesis.

Keywords: consensus, endoscopy, gastric emptying, gastroparesis, guideline, prokinetic


Publisher

European Society of Neurogastroenterology and Motility logo
European Society of Neurogastroenterology and Motility

Guideline

Consensus

Topics

Neurogastroenterology & Motility

Citation

United European Gastroenterol J.2021;9:287–30 

Published

2021

More Like This:

Gut brain axis

Gut brain axis

Jutta Keller Jutta Keller

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino, Iago Rodríguez-Lago

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris Peter Katelaris

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol Jolien Schol

Panel discussion: What's new on diverticular disease of the colon

Panel discussion: What's new on diverticular disease of the colon

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino

UEG Presentation
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
Panel discussion: What's new on diverticular disease of the colon

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Panel discussion: What's new on diverticular disease of the colon

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Event

Postgraduate Teaching Programme Barcelona 2026

Topics

Surgery Endoscopy Colorectal

Session

What’s new in diverticular disease of the colon

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

Gut brain axis

Gut brain axis

Jutta Keller Jutta Keller

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino, Iago Rodríguez-Lago

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris Peter Katelaris

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol Jolien Schol

Panel discussion: What's new on diverticular disease of the colon

Panel discussion: What's new on diverticular disease of the colon

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino

UEG Standards and Guidelines
Clinical Practice Guideline
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline


Abstract

Irritable bowel syndrome with diarrhoea (IBS-D) and functional diarrhoea (FDr) are the two major functional bowel disorders characterized by diarrhoea. In spite of their high prevalence, IBS-D and FDr are associated with major uncertainties, especially regarding their optimal diagnostic work-up and management. A Delphi consensus was performed with experts from 10 European countries who conducted a literature summary and voting process on 31 statements. Quality of evidence was evaluated using the grading of recommendations, assessment, development, and evaluation criteria. Consensus (defined as >80% agreement) was reached for all the statements. The panel agreed with the potential overlapping of IBS-D and FDr. In terms of diagnosis, the consensus supports a symptom-based approach also with the exclusion of alarm symptoms, recommending the evaluation of full blood count, C-reactive protein, serology for coeliac disease, and faecal calprotectin, and consideration of diagnosing bile acid diarrhoea. Colonoscopy with random biopsies in both the right and left colon is recommended in patients older than 50 years and in presence of alarm features. Regarding treatment, a strong consensus was achieved for the use of a diet low fermentable oligo-, di-, monosaccharides and polyols, gut-directed psychological therapies, rifaximin, loperamide, and eluxadoline. A weak or conditional recommendation was achieved for antispasmodics, probiotics, tryciclic antidepressants, bile acid sequestrants, 5-hydroxytryptamine-3 antagonists (i.e. alosetron, ondansetron, or ramosetron). A multinational group of European experts summarized the current state of consensus on the definition, diagnosis, and management of IBS-D and FDr.

Keywords: abdominal pain, clinical practice guidelines, diarrhea, FDr, functional bowel disorders, functional diarrhea, IBS-D,  irritable bowel syndrome


Publisher

European Society of Neurogastroenterology and Motility logo
European Society of Neurogastroenterology and Motility

Guideline

Clinical Practice Guideline

Topics

Neurogastroenterology & Motility

Citation

United European Gastroenterol J.2022;10:556–584

Published

2022

More Like This:

Gut brain axis

Gut brain axis

Jutta Keller Jutta Keller

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino, Iago Rodríguez-Lago

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

World Gastroenterology Organisation Global Guidelines: Helicobacter pylori

Peter Katelaris Peter Katelaris

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Jolien Schol Jolien Schol

Panel discussion: What's new on diverticular disease of the colon

Panel discussion: What's new on diverticular disease of the colon

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Edoardo Vincenzo Savarino Edoardo Vincenzo Savarino

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.